Stock listing

Hangzhou Diagens Biotechnology Co., Ltd. Class H

Selected listing: 2526 · HKEX · HKD · HK

Hangzhou Diagens Biotechnology Co., Ltd. Class H (HKEX:2526), Technology Services. Latest release Sep 30, 2026: POLL RESULTS OF THE 2026 SECOND EXTRAORDINARY…

2526:HKEXHKDHKUpdated October 3, 2026
Hangzhou Diagens Biotechnology Co., Ltd. Class H logo
Ticker
HKEX:2526
Asset type
Stock
Sector
Technology Services
Industry
Packaged Software
Exchange
HKEX
Currency
HKD

About Hangzhou Diagens Biotechnology Co., Ltd. Class H

The company specializes in biotechnology, focusing on innovative solutions in the healthcare sector. Its operations aim to enhance diagnostic capabilities and improve patient outcomes.

Latest news from Hangzhou Diagens Biotechnology Co., Ltd. Class H

POLL RESULTS OF THE 2026 SECOND EXTRAORDINARY GENERAL MEETING HELD ON SEPTEMBER 30, 2026

September 30, 2026

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

April 30, 2026

All Hangzhou Diagens Biotechnology Co., Ltd. Class H news →

Research Hangzhou Diagens Biotechnology Co., Ltd. Class H

Hangzhou Diagens Biotechnology Co., Ltd. Class H company profile

View the public company page for Hangzhou Diagens Biotechnology Co., Ltd. Class H on 6ix.

Hangzhou Diagens Biotechnology Co., Ltd. Class H news

Read company news and market updates connected to Hangzhou Diagens Biotechnology Co., Ltd. Class H.

Hangzhou Diagens Biotechnology Co., Ltd. Class H investor events

Find investor webinars, events, and replay context for Hangzhou Diagens Biotechnology Co., Ltd. Class H.

Alternate listings

HGZDY:OTC

US · USD

Alternate listing for Hangzhou Diagens Biotechnology Co., Ltd. Class H; the primary context on this page is 2526:HKEX.